Crosscheck

Your medical. Crosschecked.

Check another medication

Eyes

Carbonic anhydrase inhibitors for glaucoma

Carbonic anhydrase inhibitor, glaucoma medication
Other names: dorzolamide, Trusopt, brinzolamide, Azopt, methazolamide

FAA guidance

Acceptable in the FAA document cited.

Examiner

CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam

Source: FAA, Glaucoma and Ocular Hypertension Medications. FAA date 27 August 2025. Checked by Crosscheck 14 October 2026

The FAA lists the carbonic anhydrase inhibitors brinzolamide, dorzolamide and methazolamide as CACI glaucoma medication, as a single agent or in a combination product.

Track your medications
Show the FAA's words: Carbonic anhydrase inhibitors for glaucomaThe official FAA wording: one passage, each with its document and dateOpen
FAA, Glaucoma and Ocular Hypertension Medications · FAA date 27 August 2025
CACI Glaucoma Medications (as a single agent or in a combination product)
Carbonic Anhydrase Inhibitor: brinzolamide (Azopt), dorzolamide (Trusopt), methazolamide
Sources and dates: Carbonic anhydrase inhibitors for glaucomaTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.